chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It was increasingly difficult to ambulate; nasal congestion; runny nose; very dizzy/The dizziness became worse; clammy; developed symptoms of a urinary infection; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 13Jan2021 09:30 (Batch/Lot Number: EL3248) as [SINGLE DOSE] for covid-19 immunisation; fexofenadine hydrochloride (MUCINEX ALLERGY), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at for nasal congestion, rhinorrhoea; loratadine, pseudoephedrine sulfate (CLARITIN-D), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at for nasal congestion; trimethoprim (TRIMETHOPRIM), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at for urinary tract infection. Medical history included multiple sclerosis from an unknown date and unknown if ongoing. Known allergies: Penicillin, Tetracycline, Topiramate, Iodinated Diagnostic Agents. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. She had other medications in two weeks. No covid prior vaccination. It was reported that they were not sure that it was due to vaccine received on 13Jan2021. Approximately 2 days following vaccine, 15Jan2021, she experienced nasal congestion & runny nose. She took Mucinex for i dose (she had allergies & have taken it many times with no problems) she became very dizzy & clammy. 2 days later the patient experienced nasal congestion and took Claritin D. The dizziness became worse. She stopped it. She had Multiple Sclerosis. She developed symptoms of a urinary infection that she self medicate with Trimethoprim. The patient became increasingly more dizzy so she called her Dr. She went to office because it was increasingly difficult to ambulate due to dizziness. She ordered lab work & a Covid test (post vaccination SARS-COV-2) on 27Jan2021 that was negative. The dizziness was getting better but still present. The patient was due to have her 2nd vaccine Wednesday 03Feb2021. They just wanted to be sure it is safe to proceed. AE resulted in Doctor or other healthcare professional office/clinic visit. Outcome of the events was recovering.
Had the shot and got them now/ Suspected vaccination failure; Still getting shingles, got them now, Shingles twice; Very painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had twice).   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the shot and got them now/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Still getting shingles, got them now, Shingles twice) and pain (Verbatim: Very painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 02-APR-2023 This case was reported by a patient via interactive digital media. The reporter reported that he/she had shingles shots 2 years ago but got shingles at the time of reporting. They were very painful.  The follow-up could not be possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.
My 21 1/2 month old son broke out with a rash that spreaded from waist to right knee and left shoulder. It's going away, I called his primary doctor.
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053c21a and 027C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date).    The Race of the patient was reported as Other.  No Concomitant products reported.  Pharmacist reported that they had more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 day beyond use date.   These are the lot number for the monovalent vaccines with their corresponding beyond use dates. For the lot number 027C21A the beyond use date was 21 May 2021 and for the lot 053C21A the beyond use date was 01 Jul 2021.   No treatment products reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow up received contains non significant information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
chronic itch to left arm at injection sight. He reports that it feels like something is moving around inside his left arm he  notes intermittently he exp's muscles tightness to left arm that radiates almost to his neck.   pt has applied triamcinolone 0.1% cream to his arm that did stop itch but caused a blister to the area that healed after he stopped using it.
pt recvd vax; high fever 3-5 days p/ shot;t 106,ear thermometer;1 wk later rash occured,lasted 3 1/2 days; MD said it was Roseolla;
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored PROQUAD (Merck) (strength, dosage and frequency), lot# L006390 with expiration date of 26-AUG-2015, orally (incorrect product storage). This is one of several reports received from the same reporter. Additional information has been requested.
Within 12 hours had high fever 102, taking Tylenol to reduce. Still have fever almost 48 hours later. Fever, chills, body aches, nausea.
Huge boil covering inside of upper arm that stretched from elbow to shoulder. It was on the same arm that vaccine was given, opposite side of arm, however. Area where the vaccine was actually administered felt hard and was painful upon touching.
Patient experienced flu like symptoms the morning after receiving his vaccine (1/29).  Symptoms improved by 1/31).  On 2/1, patient woke up with a rash all over his body that was pruritic.  Patient took Benadryl which helped improve his symptoms.  Today (2/2), patient woke up with angioedema.  He took another Benadryl--symptoms improved.  Denies SOB, tongue swelling, itchy throat, or wheezing.  Swelling is localized to lips only.
Swelling of face, eyes, lips. Still having problem with lips cracked and rough, had some dizziness, nausea, sores on nose, stomach pressure all starting within 24 hrs of immunization. Symptoms resolved other than cracked lips.
About four hours following vaccination, the patient called the pharmacy with symptoms of arm pain at injection site, shoulder pain in left shoulder, and decreased range of motion in left shoulder. The patient also stated that he felt the vaccine had been given too high on the arm causing his symptoms.
hives, extreme fatigue in neck, shoulder aching muscles in arms; flushed face;
Runny nose, fatigue, muscle spasms, hypertension, pre-diabetes, high cholesterol, body aches, shortness of breath, dizziness, frequent  urination, constant coughing, dehydration, sneezing, throat pain, and chills.
10-22- Felt off. 10-23- 48 hours after vacc started shaking violently-very cold-lasted 2 hours. Temp 103.3. TYLENOL bought temp down into 100-101. Severe headache-couldn't work, even read or watch TV. Sick for 7 days.
Patient presented with chest pain that started 3 days after second dose of Pfizer vaccine. He had chest pain, shortness of breath. EKG did show some borderline ST elevations in the anterolateral leads. Troponin was performed which was elevated at 5 initially. Plan is for admission for further workup and management.
This spontaneous report was received from a physician and refers to a 16 year old female patient. The patient did not had pertinent medical history and no known drug allergies. Concomitant therapies included ADDERALL XR, ZOLOFT and magnesium hydroxide. On 10-FEB-2017, the patient reported to office for administration of her third series of GARDASIL 9 intramuscularly, lot # M026306, expiration date 30-APR-2018 (dose was not reported) for prevention of cervical cancer as the patient was in childbearing age group. After administration of the vaccine, the patient returned to the office on 13-FEB-2017 and reported redness and minor swelling around the injection site. Additionally, the patient developed small blister slightly anterior to injection site and itchiness related to injection. The physician treated the patient with ibuprofen and BENADRYL. At the time of reporting, the patient was recovering from the events. No lab diagnostics studies were performed and no product quality complain was reported. The causal relationship between GARDASIL 9 and the events was not provided. Additional information has been requested.
Itchy hives in multiple areas on body, some facial swelling of lips, eyes, and forehead. Back pain and continuous vomiting.
I had hot flashes/cold flashes, numb toes, mouth dryness. I also had some hair loss and very dry hair. I also lost a lot of hair on my temple. I also have an itchy ear.
Previously healthy patient was admitted to hospital 10/22-10/23/03 and diagnosed with asthma and viral respiratory illness. Prior to discharge, influenza vaccine 0.5 mL was administered IM in left upper arm. Two days later family members noticed patient limping and c/o left lower extremity pain. Pain/inability to move LLE continued at home. Patient was readmitted 10/28/03 with diagnosis "transverse myelitis vs. atypical Guillan-Barre."  MRI showed demyelinating lesion in lumbar spine. While hospitalized 10/28/03 to 12/3/03, patient received intravenous immune globulin, intravenous steroids, azithromycin and multiple other medications. During hospitalization family expressed concern about a possible speech/hearing problem but audiology consult revealed normal hearing in one hear, unable to assess other ear due to patient not cooperative. Patient required physicial therapy and brace to assist walking. Discharged to home 12/3/03 with plans to continue physical therapy.  Nurse follow up on 08/04/04 states: "spasm." Discharge summary states fever. msv
PT HAD LOCAL PAIN AT INJECTION SITE AND PT ALSO HAD BRUISING  AT INJECTION SITE(LARGE AREA). PT TOOK OTC PAIN MEDICATIONS AND WARM COMPRESSES. PT CAME BACK TODAY 9/19/2023 AND HAVE SIGNS OF HEALING (YELLOWING AROUND BRUISE).
Itchy; Mass under the skin; Lump the size of a golfball on arm; Redness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), VACCINATION SITE MASS (Mass under the skin), VACCINATION SITE MASS (Lump the size of a golfball on arm) and VACCINATION SITE ERYTHEMA (Redness around injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced PRURITUS (Itchy), VACCINATION SITE MASS (Mass under the skin), VACCINATION SITE MASS (Lump the size of a golfball on arm) and VACCINATION SITE ERYTHEMA (Redness around injection site). At the time of the report, PRURITUS (Itchy), VACCINATION SITE MASS (Mass under the skin), VACCINATION SITE MASS (Lump the size of a golfball on arm) and VACCINATION SITE ERYTHEMA (Redness around injection site) outcome was unknown.            No concomitant medications were reported. Treatment information was not provided by the reporter.
pt presented to ED with generalized weakness, diarrhea, vomiting, poor oral intake, mild cough, sore throat; CT scan showed acute cholecystitis; positive COVID test; COVID pneumonia; started on ABX, steroids, O2 supplementation; pt improved and was able to be sent home; she passed away at home; death certificate and med records sent to info@vaers.org per VAERS request
Stomach cramps; I have not energy to do anything/feels weak; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 09Nov2021 (Lot number: FD7220) at the age of 55 years as dose 2, single (time the vaccination was given: little before or after 7:00am) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st Dose, Lot Number / Expiry Date: FF8841, Route, Anatomical Location: Left arm, First dose: had a cold), administration date: 19Oct2021, when the patient was 55 years old, for COVID-19 Immunization, reaction(s): "had a cold", "stomach pain", "arm was sore too, couldn't hardly lift it", "hoarse, couldn't hardly talk", "couldn't hardly talk". The following information was reported: ABDOMINAL PAIN UPPER (non-serious) with onset Nov2021, outcome "not recovered", described as "Stomach cramps"; ASTHENIA (non-serious) with onset Nov2021, outcome "unknown", described as "I have not energy to do anything/feels weak".  Additional information: Patients details included height: 5'6 or 5'7, weight: 240 something. Patient did not received any other vaccine within 4 weeks before the vaccination. Since she took the second vaccine, she keeps having stomach cramps and she was not having stomach cramps in 8 years. The patient stated that she was trying to get an appoint but her stomach keeps nagging her and she was drained. The events did not require any emergency room or physician office visit.  No follow-up attempts are possible. No further information is expected.
I had a minor sore throat and a little cough. They lasted about 5 days and were very minor. I was prescribed an antiviral medication by the Nurse, which I took for 5 days, 10 pills.
mom states child stopped breathing, eyes fixed, then had sz in ER, admitted to PICU;
I felt fine until the morning of Jan. 10 (except for very painful arm).  I was awakened early in the morning by severe vertigo (my eyes were blinking rapidly and the room was spinning violently); I was nauseous and couldn't lie down without the violent spinning re-occurring.  I was very dizzy and exhausted the whole day, unable to function.  The next day I continued to be very dizzy and off-balance, couldn't work but better than prior day.  Each day, same symptoms have continued but milder.  I called my PCP on Monday, Jan 11.  He told me it sounded like an inner ear problem, probably unrelated to the vaccine and to call him the next day and report my symptoms.  I did (Tues. Jan 12) and reported dizziness was milder but still there.  He suggested I see an ENT doctor.
Plugged ears, dizziness, hard to concentrate, vertigo, going on 3 days and not better. Had slight fever for 1 day, body aches, fatigued, sore at injection site, lasted 1 day
fever 100, general rash;APAP given;as of 27JUN rash present, afeb advised to contact PMD for f/u;
Nausea, headache, fatigue, pain at injection site muscle pain for 24 hours after.
Arm was swollen on her biceps; Arm was also red past her elbow; Arm was very sore; for 3-4 nights could not roll over on arm; This case was reported by a consumer via call center representative and described the occurrence of local swelling in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included mosquito bite.   On 6th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 6th June 2019, less than a day after receiving Shingrix, the patient experienced local swelling and localized erythema. In June 2019, the patient experienced pain in arm and movement disorder. On 6th August 2019, the outcome of the local swelling and localized erythema were resolved with sequelae. On an unknown date, the outcome of the pain in arm was unknown and the outcome of the movement disorder was recovered/resolved.   It was unknown if the reporter considered the local swelling, localized erythema, pain in arm and movement disorder to be related to Shingrix.  Additional case details were provided as follows: The patient reporter for herself. The patient had an Epipen because she usually got reactions to mosquito bites.  The patient got her Shingrix shot in the left arm.  The patient's arm was very sore and for 3 to 4 nights she could not roll over on her arm.  Her arm was also red past her elbow.  This time, she did not need to use the Epipen. On day 10, when she took a picture of her arm, it was red and swollen on her biceps. The patient was wondering whether she should get the 2nd shot and was very apprehensive. The patient referred back to her health care provider.  The patient did not consent to follow-up.
no adverse event; expired VAQTA was administered; This spontaneous report was received from Consumer, concerning a patient of unspecified age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 02-MAY-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 ml, lot #T037329, expiration date: 30-APR-2022, administered for prophylaxis (strength, and route of administration were not provided)(expired vaccine used).   Caller confirmed that the product had no temperature excursions and was stored properly. No additional adverse event (AE) information was provided.
pt was nervous,  blood pressure was taken as a precaution.  bp was 119/74.  had pt sit longer x 10 minutes and relax, sip and water to cvs.
Dizziness, blurred vision, extreme aches, joint aches, difficulty walking, nausea, fever, chills, throw up, rash all over body, difficulty breathing, migraine
Patient developed a tonic clonic seizures (2/17/15). Patient received PREVNAR 13 the day prior to the seizure episode. He had fever and there is history of febrile seizure.
Patient thought she had a flu; Freezing and couldn't get warm; Her arm was about to kill her; Fever of 101; Chills; Nauseated; Body aches from her toes to her head; The lymph node under her left arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Patient thought she had a flu), FEELING COLD (Freezing and couldn't get warm), PAIN IN EXTREMITY (Her arm was about to kill her), PYREXIA (Fever of 101) and CHILLS (Chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2021, the patient experienced INFLUENZA LIKE ILLNESS (Patient thought she had a flu), FEELING COLD (Freezing and couldn't get warm), PAIN IN EXTREMITY (Her arm was about to kill her), PYREXIA (Fever of 101), CHILLS (Chills), NAUSEA (Nauseated), MYALGIA (Body aches from her toes to her head) and LYMPH NODE PAIN (The lymph node under her left arm). At the time of the report, INFLUENZA LIKE ILLNESS (Patient thought she had a flu), FEELING COLD (Freezing and couldn't get warm), PAIN IN EXTREMITY (Her arm was about to kill her), PYREXIA (Fever of 101), CHILLS (Chills), NAUSEA (Nauseated), MYALGIA (Body aches from her toes to her head) and LYMPH NODE PAIN (The lymph node under her left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not  provided.  Patient  thought she was going to die Saturday and yesterday(Friday). patient thought she had COVID. The patient states she is feeling better today 18Oct2021.
Initial unsolicited report received from a consumer via other company(pfizer) on 25 November 2015. This case involves a 74-years-old male patient who was vaccinated with a dose of INFLUENZA VACCINE (Influenza vaccine)(batch number, route and site of administration, dose, dose in series were not reported) and also received a dose of PREVNAR 13 (batch number ,route and site of administration, dose, dose in series were not reported) on 3 November 2015. The patient hadn't had flu shot within last twenty years. The patient's medical history was reported as underactive thyroid. The patient's concomitant medication includes Thyroxine (75 mcg one a day) for Underactive thyroid. On 4 November 2015, one day following the vaccination, the patient felt lousy for 2-3 weeks. The patient's laboratory data and corrective treatment were not reported. The patient was recovering from the event ans was still lousy. List of documents held by sender: none. Follow up received from consumer on 24 December 2015. It was reported that the patient was recovered from the event without medical intervention.